Company intelligence / Profile preview

Wuhan Jinnuosai

Ownership: Private
Development stage: Other

Overview

Wuhan Jinnuosai Biotechnology is a specialized life sciences company focused on the development and production of high-performance cell culture media. Based in the Wuhan National Bio-industry Park (Biolake), the company offers a wide range of products including serum-free, chemically defined, and customized media for various mammalian and insect cell lines such as CHO, HEK293, and Vero. Their portfolio supports the upstream bioprocessing needs of pharmaceutical companies and research institutions working on vaccines, monoclonal antibodies, and recombinant proteins. In addition to product supply, Wuhan Jinnuosai provides technical services such as media screening, process optimization, and cell line adaptation. The company aims to provide cost-effective, high-quality alternatives to imported media products within the Chinese biopharmaceutical market.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Wuhan Jinnuosai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Jinnuosai.